Target intelligence / Profile preview

Group 5 allergen (Dactylis glomerata) (Dac g 5)

Target
Dac g 5
Molecular classification
Allergen, Poa p IX/Phl p VI allergen family
01

Overview

Dac g 5 is a major protein allergen found in the pollen of Dactylis glomerata, commonly known as Orchard grass or Cocksfoot grass (UniProt: Q93WP9). It belongs to the group 5 grass pollen allergen family, which is recognized as one of the most potent triggers of IgE-mediated Type I hypersensitivity in individuals with hay fever or allergic asthma (Allergen.org). Biologically, group 5 allergens are thought to play a role in pollen tube growth and development within the plant, although their exact physiological function is still being elucidated. In humans, exposure to Dac g 5 via inhalation leads to the cross-linking of allergen-specific IgE on the surface of mast cells and basophils, triggering the release of inflammatory mediators like histamine that cause allergic symptoms. As a therapeutic target, Dac g 5 is the primary component used in allergen-specific immunotherapy (AIT) to desensitize patients and induce long-term immune tolerance. AIT products, such as the five-grass pollen sublingual tablet (Oralair) or standardized subcutaneous extracts, work by gradually exposing the immune system to the allergen to shift the response from a pro-allergic Th2 profile to a regulatory or Th1-mediated profile. This process is typically monitored through biomarkers such as increased allergen-specific IgG4 blocking antibodies and reduced skin prick test reactivity.

Other names
Major allergen Dac g 5Cocksfoot grass pollen allergenOrchard grass pollen allergenDac g V
02

Mechanism of action

Allergen-specific immunotherapy (AIT) induces immune tolerance by shifting the T-cell response from Th2 to Th1, promoting regulatory T-cell (Treg) activity, and increasing the production of allergen-specific IgG4 blocking antibodies.

03

Biological functions

Immune responsePollen developmentPollen tube growth
04

Disease associations

Allergic rhinitisAllergic conjunctivitisAsthma
05

Safety considerations

AnaphylaxisLocal allergic reactions (e.g., oral pruritus, throat irritation)Systemic allergic reactions
06

Interacting drugs

Five-grass pollen sublingual tablet (Oralair)

1 more in the full profile.

07

Biomarkers

Allergen-specific IgE (sIgE)Allergen-specific IgG4Skin Prick Test (SPT) reactivity

Beyond the preview

Go deeper on Group 5 allergen (Dactylis glomerata) (Dac g 5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Group 5 allergen (Dactylis glomerata) (Dac g 5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call